RxDoctor Payments Data

Thomas Ledbetter

Internal Medicine · Waxahachie, TXNPI 1760426092

Payments from drug & device makers

$901,210in general payments, 2019–2025

Across 183 payments — averaging $4924.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$613K
  • GSK$97K
  • Eli Lilly$84K
  • Teva Pharmaceuticals USA, Inc.$33K
  • Gilead$27K
  • Astrazeneca UK Limited$19K
  • plus $28K from 6 others

What the payments were for

  • Food & beverage$135100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)126$612,742
GSK9$97,023
Eli Lilly6$83,997
Teva Pharmaceuticals USA, Inc.23$32,571
Gilead5$27,092
Astrazeneca UK Limited1$19,365
Modernatx, Inc.6$13,637
Pfizer3$11,171
AstraZeneca1$3,542
Intuitive Surgical1$26
Corcept Therapeutics1$25
Johnson & Johnson1$19

How this compares

$901,210 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$14,403
Zolpidem Tartrate11$7

Paid to pharmacies, not to this prescriber.

Other internal medicine in Waxahachie

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →